Publication|Articles|November 14, 2025
Supplements and Featured Publications
- Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations
Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations
Advertisement
This clinical brief is supported by Celltrion Inc.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
2
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
3
First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA
4
Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery
5